2011 annual financial data
Tenax Therapeutics 2011 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,024.69%.
Operating income was -8,220,197 USD and net income was -15,712,410 USD.
Operating cash flow was -8,403,142 USD.
Get free Tenax Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 415,034 USD
- Operating income
- -8,220,197 USD
- Net income
- -15,712,410 USD
- Operating cash flow
- -8,403,142 USD